✦ LIBER ✦

Growth hormone response in low-dose apomorphine test correlates with nigrostriatal dopamine transporter binding in patients with Parkinson’s disease

✍ Scribed by S. Happe; T. Tings; W. Koch; J. Welsch; K. Helmschmied; P. C. Baier; J. Meller; W. Wuttke; W. Paulus; K. Tatsch; C. Trenkwalder

Publisher: Springer
Year: 2006
Tongue: English
Weight: 116 KB
Volume: 114
Category: Article
ISSN: 1435-1463
DOI: 10.1007/s00702-006-0611-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Levodopa treatment does not affect low-d

Levodopa treatment does not affect low-dose apomorphine test in patients with Parkinson's disease

✍ Svenja Happe; Tobias Tings; Kathrin Helmschmied; Karin Neubert; Wolfgang Wuttke; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

## Abstract Challenge with low‐dose apomorphine causes a significant rise in growth hormone (GH) in patients with Parkinson's disease (PD) compared to controls and patients with multiple system atrophy (MSA) who have not previously received dopaminergic treatment. To date, it has not been demonstra